Targeting myeloid-derived suppressor cells using a novel adenosine monophosphate-activated protein kinase (AMPK) activator-Reference-Cited by-同舟云学术

Targeting myeloid-derived suppressor cells using a novel adenosine monophosphate-activated protein kinase (AMPK) activator

Published:2016-07-25 Issue:9 Volume:5 Page:e1214787
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Trikha Prashant,Plews Robert L.,Stiff Andrew,Gautam Shalini,Hsu Vincent,Abood David,Wesolowski Robert,Landi Ian,Mo Xiaokui,Phay John,Chen Ching-Shih,Byrd John,Caligiuri Michael,Tridandapani Susheela,Carson William E.

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1080/2162402X.2016.1214787

Reference46 articles.

1. Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression

2. The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells

3. Myeloid-derived suppressor cell heterogeneity in human cancers

4. Myeloid-derived suppressor cells as regulators of the immune system

5. Signaling pathways involved in MDSC regulation

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of myeloid-derived suppressor cell-mediated immunosuppression in colorectal cancer and related therapies;World Journal of Gastrointestinal Oncology;2024-05-15

2. Exploring the Potential of Glycolytic Modulation in Myeloid-Derived Suppressor Cells for Immunotherapy and Disease Management;Immune Network;2024

3. Oncogenic PIK3CA recruits myeloid‐derived suppressor cells to shape the immunosuppressive tumour microenvironment in luminal breast cancer through the 5‐lipoxygenase‐dependent arachidonic acid pathway;Clinical and Translational Medicine;2023-11

4. BTK inhibition potentiates anti-PD-L1 treatment in murine melanoma: potential role for MDSC modulation in immunotherapy;Cancer Immunology, Immunotherapy;2023-08-02

5. ICAM-1-decorated extracellular vesicles loaded with miR-146a and Glut1 drive immunomodulation and hinder tumor progression in a murine model of breast cancer;Biomaterials Science;2023